findmyKOL
Clinical trialNCT01239355TerminatedPhase 2Interventional

MK2206 in Treating Patients With Advanced Liver Cancer That Did Not Respond to Previous Therapy

SponsorNational Cancer Institute (NCI)Enrollment15Adult Hepatocellular CarcinomaAdvanced Adult Hepatocellular CarcinomaLocalized Non-Resectable Adult Liver CarcinomaRecurrent Adult Liver Carcinoma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

22 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Tower Cancer Research Foundation

    Beverly Hills, California, United States

  • City of Hope Medical Center

    Duarte, California, United States

  • Usc Norris Comprehensive Cancer Center

    Los Angeles, California, United States

  • University of California Davis Comprehensive Cancer Center

    Sacramento, California, United States

  • University of Chicago Comprehensive Cancer Center

    Chicago, Illinois, United States

  • Decatur Memorial Hospital

    Decatur, Illinois, United States

  • Northshore University Healthsystem-Evanston Hospital

    Evanston, Illinois, United States

  • Ingalls Memorial Hospital

    Harvey, Illinois, United States

  • Joliet Oncology-Hematology Associates Limited

    Joliet, Illinois, United States

  • Loyola University Medical Center

    Maywood, Illinois, United States

  • Illinois Cancercare-Peoria

    Peoria, Illinois, United States

  • Central Illinois Hematology Oncology Center

    Springfield, Illinois, United States

  • Southern Illinois University

    Springfield, Illinois, United States

  • Fort Wayne Medical Oncology and Hematology Inc-Parkview

    Fort Wayne, Indiana, United States

  • Northern Indiana Cancer Research Consortium

    South Bend, Indiana, United States

  • University of Maryland/greenebaum Cancer Center

    Baltimore, Maryland, United States

  • University of Michigan

    Ann Arbor, Michigan, United States

  • Oncology Care Associates Pllc

    Saint Joseph, Michigan, United States

  • Saint John'S Mercy Medical Center

    St Louis, Missouri, United States

  • Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center

    Columbus, Ohio, United States

  • Penn State Milton S Hershey Medical Center

    Hershey, Pennsylvania, United States

  • University of Pittsburgh

    Pittsburgh, Pennsylvania, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Dec 2010
Primary completion
28 Feb 2013
Completion
28 Feb 2013
Last update posted
5 Oct 2015
Registered enrollment
15
Registry id
NCT01239355

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.